TNF-α inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression

Journal of Immunology

Volumn 163, Issue 7, 1999, Pages 3653-3661

  Lane, Brian R ^a   Markovitz, David M ^a   Woodford, Nina L ^b   Rochford, Rosemary ^b   Strieter, Robert M ^a   Coffey, Michael J ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG ALVEOLUS MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION;

ADJUVANTS, IMMUNOLOGIC; ANTIVIRAL AGENTS; CELL MEMBRANE; CHEMOKINES, CC; DOWN-REGULATION; HIV-1; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MACROPHAGES, ALVEOLAR; MONOCYTES; RANTES; RECEPTORS, CCR5; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 0033215122     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Gartner, S., P. Markovits, M. Markovitz, M. Kaplan, R. Gallo, and M. Popovic. 1986. The role of mononuclear phagocytes in HTLV-III LAV infection. Science 233:215.
2. Fauci, A. 1987. AIDS: immunopathogenic mechanisms and research strategies. Clin. Res. 35:503.
3. + T cell depletion and viral replication in SIV infection. Science 280:427.
4. Schnittman, S., M. Psallidopoulos, H. Lane, L. Thompson, M. Baseler, F. Massari, C. Fox, N. Salzman, and A. Fauci. 1989. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245:305.
5. Meltzer, M., D. Skillman, P. Gomatos, D. Kalter, and H. Gendelman. 1990. Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. Annu. Rev. Immunol. 8:169.
6. Finzi, D., and R. Silicano. 1998. Viral dynamics in HIV-1 infection. Cell 93:665.
7. Poli, G., and A. S. Fauci. 1995. Role of cytokines in the pathogenesis of human immunodeficiency virus infection. In Human Cytokines: Their Role in Disease and Therapy. B. B. Aggarwal, and R. K. Puri, eds. Blackwell, Cambridge, p. 421.
8. Lahdevirta, J., C. Maury, A. Teppo, and H. Repo. 1988. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85:289.
9. Merrill, J., Y. Koyanagi, and I. Chen. 1989. Interleukin-1 and tumor necrosis factor α can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J. Virol. 63:4404.
10. Herbein, G., S. Keshav, M. Collin, L. Montaner, and S. Gordon. 1994. HIV-1 induces tumor necrosis factor and IL-1 gene expression in primary human macrophages independent of productive infection. Clin. Exp. Immunol. 95:442.
11. Karsten, V., S. Gordon, A. Kim, and G. Herbein. 1996. HIV-1 envelope glycoprotein gp120 down-regulates CD4 expression in primary human macrophages through induction of endogenous tumor necrosis factor-α. Immunology 88:55.
12. Bazzoni, F., and B. Beutler. 1996. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334:1717.
13. Osborn, L., S. Kunkel, and G. Nabel. 1989. Tumor necrosis factor α and interleukin 1 stimulate human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc. Natl. Acad. Sci. USA 86:2336.
14. Folks, T., K. Clouse, J. Justement, A. Rabson, E. Duh, J. Kehrl, and A. Fauci. 1989. Tumor necrosis factor α induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86:2365.
15. Duh, E. J., W. J. Maury, T. M. Folks, A. S. Fauci, and A. B. Rabson. 1989. Tumor necrosis factor α activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86:5974.
16. Griffin, G. E., K. Leung, T. M. Folks, S. Kunkel, and G. J. Nabel. 1989. Activation of HIV gene expression during monocyte differentiation by induction of NF-κB. Nature 339:70.
17. Michihiko, S., N. Yamamoto, F. Shinozaki, K. Shimada, G. Soma, and N. Kobayashi. 1989. Augmentation of in-vitro HIV replication in peripheral blood mononuclear cells of AIDS and ARC patients by tumor necrosis factor. Lancet 27:1206.
18. Mellors, J., B. Griffith, M. Ortiz, M. Landy, and J. Ryan. 1991. Tumor necrosis factor-α/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J. Infect. Dis. 163:78.
19. Li, Q., K. Gebhard, T. Schacker, K. Henry, and A. T. Haase. 1997. The relationship between tumor necrosis factor and human immunodeficiency virus gene expression in lymphoid tissue. J. Virol. 71:7080.
20. Herbein, G., L. Montaner, and S. Gorden. 1996. Tumor necrosis factor α inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor. J. Virol. 70:7388.
21. Herbein, G., and S. Gordon. 1997. 55- and 75-kilodalton tumor necrosis factor receptors mediate distinct actions in regard to human immunodeficiency virus type 1 replication in primary human macrophages. J. Virol. 71:4150.
22. Coffey, M., C. Woffendin, S. Phare, R. Strieter, and D. Markovitz. 1997. RANTES inhibits HIV-1 replication in human peripheral blood monocytes and alveolar macrophages. Am. J. Physiol. 272:L1025.
23. Simmons, G., P. R. Clapham, L. Picard, R. E. Offord, M. M. Rosenkilde, T. W. Schwartz, R. Buser, T. N. C. Wells, and A. E. Proudfoot. 1997. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 276:276.
24. Moriuchi, H., M. Moriuchi, and A. Fauci. 1997. Nuclear factor-κB potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J. Immunol. 158:3483.
25. McManus, C. M., C. F. Brosnan, and J. W. Berman. 1998. Cytokine induction of MIP-1α and MIP-1β in human fetal microglia. J. Immunol. 160:1449.
26. Choe, H., M. Farzan, Y. Sun, N. Sullivan, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1996. The β-chemokines receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135.
27. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. Sutton, C. Hill, et al. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661.
28. Doranz, B., J. Rucker, Y. Yi, R. Smyth, M. Samson, S. Peiper, M. Parmentier, R. Collman, and R. Doms. 1996. A dual-tropic, primary HIV-1 isolate that uses Fusin and the β-chemokine receptors CKR -5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149.
29. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667.
30. Liu, R., W. Paxton, S. Choe, D. Ceradini, S. Martin, R. Horuk, M. MacDonald, H. Stuhlmann, R. Koup, and N. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367.
31. Samson, M., F. Libert, B. J. Doranz, J. Rucker, C. Liesnard, C. M. Farber, S. Saragosti, C. Lapoumeroulie, J. Cognaux, C. Forceille, et al. 1996. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722.
32. Dean, M., M. Carrington, C. Winkler, G. A. Huttley, M. W. Smith, R. Allikmets, J. J. Goedert, S. P. Buchbinder, E. Vittinghoff, E. Gomperts, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene: Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study [published erratum appears in 1996, Science 274:1069]. Science 273:1856.
33. + T cells. Science 270:1811.
34. Potts, B. 1990. Techniques in HIV Research, Stockton, New York.
35. Evanoff, H. L., M. D. Burdick, S. A. Moore, S. L. Kunkel, and R. M. Strieter. 1992. A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1). Immunol. Invest. 21:39.
36. Rochford, R., M. J. Cannon, R. E. Sabbe, K. Adusumilli, G. Picchio, J. M. Glynn, D. J. Noonan, D. E. Mosier, and M. V. Hobbs. 1997. Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell lines. Viral Immunol. 10:183.
37. Mangan, D. F., G. R. Welch, and S. M. Wahl. 1991. Lipopolysaccharide, tumor necrosis factor-α, and IL-1β prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J. Immunol. 146:1541.
38. DeLuca, C., H. Kwon, N. Pelletier, M. A. Wainberg, and J. Hiscott. 1998. NF-κB protects HIV-1-infected myeloid cells from apoptosis. Virology 244:27.
39. Khandaker, M., G. Mitchell, L. Xu, J. Andrews, R. Singh, H. Leung, J. Madrenas, S. Ferguson, R. Feldman, and D. Kelvin. 1999. Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-α-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression. Blood 93:2173.
40. Dezube, B., M. Lederman, J. Spritzler, B. Chapman, J. Korvick, C. Flexner, S. Dando, M. Mattiacci, C. Ahlers, L. Zhang, W. Novick, Jr., et al. 1995. High-dose pentoxifylline in patients with AIDS: inhibition of tumor necrosis factor production. J. Infect. Dis. 171:1628.
41. Khoo, S., L. Pepper, N. Snowden, A. Hajeer, P. Vallely, E. Wilkins, B. Mandal, and W. Ollier. 1997. Tumour necrosis factor c2 microsatellite allele is associated with the rate of HIV disease progression. AIDS 11:423.
42. Aukrust, P., F. Muller, E. Lien, I. Nordoy, L. Nina-Beate, D. Kvale, T. Espevik, and S. Froland. 1999. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. J. Infect. Dis. 179:74.